IP Library Patent Application 15012061
Patent Application
App. No. 15/012,061

ADIPOSE DERIVED ADULT STEM CELLS IN HEPATIC REGENERATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/012,061
Abstract

The present invention provides a method to derive hepatic stem cells from stem cells derived from non-liver tissue. In one embodiment of the invention, hepatic stem cells are derived from adipose stem cells. The invention also provides a method of enhancing hepatic cytokine production (e.g., HGF) from ASCs, which may be useful in the regeneration of liver tissue when transplanted in vivo. Tissue culture conditions, including media conditions, are provided.

Claims (19)

1 . A method of deriving hepatic stem cells from non-liver stem cells comprising:

(a) providing stem cells derived from non-liver tissue; and

(b) culturing the stem cells on an extracellular matrix comprising at least one fibrilar matrix protein and in serum-free culture medium comprising hepatic growth factor (HGF),

in which the stem cells derived from non-liver tissue differentiate into hepatic stem cells.

2 . The method according to claim 1 in which the non-liver tissue is adipose tissue.

3 . The method according to claim 1 in which the non-liver tissue is tissue from an adult mammal.

4 . The method according to claim 1 in which the at least one fibrilar matrix protein is selected from the group consisting of collagen I and collagen III.

5 . The method according to claim 4 in which the at least one fibrilar matrix protein is collagen I.

6 . The method according to claim 1 in which the culture medium further comprises Oncostatin M, DMSO or both.

7 . The method according to claim 1 in which the extracellular matrix further comprises fibronectin, matrigel, vitrogen or combinations thereof.

8 . The method according to claim 1 in which greater than about 70% of the stem cells derived from non-liver tissue differentiate into hepatic stem cells.

9 . The method of claim 1 in which the stem cells derived from non-liver tissue were further derived from passage in culture.

10 . A method of inducing HGF expression from non-liver stem cells comprising:

(a) providing stem cells derived from non-liver tissue; and

(b) culturing the stem cells on an extracellular matrix comprising at least one fibrilar matrix protein and in serum-free culture medium comprising EGF, bFGF, or both,

in which the stem cells derived from non-liver tissue produce HGF.

11 . The method of claim 10 in which the culture medium comprises EGF and bFGF.

12 . The method of claim 10 in which the culture medium further comprises sodium ascorbic diphosphate.

13 . The method of claim 11 in which the culture medium further comprises sodium ascorbic diphosphate.

Assignments (3)
MERGER Recorded Sep 7, 2016
From: ARTECEL, INC.
To: COGNATE BIOSERVICES, INC.
Reel/Frame 039662/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2016
From: LUDLOW, JOHN W.
To: ARTECEL, INC.
Reel/Frame 038397/0387 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2016
From: GIMBLE, JEFFREY M.
To: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
Reel/Frame 038397/0399 →